Video interview with CEO Carlos de Sousa about the company’s recent top-line data readout for NIPU and its implications for UV1 going forward

Redeye interviews Ultimovacs’ CEO Carlos de Sousa. They talk about the company’s recent top-line data readout for NIPU and its implications for UV1 going forward.

See the full interview here